Systematic variation in gene expression patterns in human cancer cell lines.

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol (2002) 82.19

Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res (2002) 40.03

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature (2012) 31.78

Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol Biol Cell (2002) 17.32

The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev (2008) 15.01

Gene selection and classification of microarray data using random forest. BMC Bioinformatics (2006) 12.45

Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res (2010) 10.90

Coexpression analysis of human genes across many microarray data sets. Genome Res (2004) 9.38

MatchMiner: a tool for batch navigation among gene and gene product identifiers. Genome Biol (2003) 8.66

Chemosensitivity prediction by transcriptional profiling. Proc Natl Acad Sci U S A (2001) 7.51

Gene expression patterns in human liver cancers. Mol Biol Cell (2002) 6.93

Elevated CRAF as a potential mechanism of acquired resistance to BRAF inhibition in melanoma. Cancer Res (2008) 6.05

Real-time expression profiling of microRNA precursors in human cancer cell lines. Nucleic Acids Res (2005) 5.44

Genome-wide expression profiling of mid-gestation placenta and embryo using a 15,000 mouse developmental cDNA microarray. Proc Natl Acad Sci U S A (2000) 5.38

A prediction-based resampling method for estimating the number of clusters in a dataset. Genome Biol (2002) 5.15

DOT1L/KMT4 recruitment and H3K79 methylation are ubiquitously coupled with gene transcription in mammalian cells. Mol Cell Biol (2008) 4.56

A global view of pleiotropy and phenotypically derived gene function in yeast. Mol Syst Biol (2005) 3.70

Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays. Proc Natl Acad Sci U S A (2003) 3.66

Revisiting global gene expression analysis. Cell (2012) 3.63

Let-7 expression defines two differentiation stages of cancer. Proc Natl Acad Sci U S A (2007) 3.59

GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model. Cancer Cell (2008) 3.44

Microarray results: how accurate are they? BMC Bioinformatics (2002) 3.23

Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth. Mol Syst Biol (2011) 3.15

Tumor reversion: correction of malignant behavior by microenvironmental cues. Int J Cancer (2003) 3.02

Serum vascular endothelial growth factor and fibronectin predict clinical response to high-dose interleukin-2 therapy. J Clin Oncol (2009) 3.02

A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt. Proc Natl Acad Sci U S A (2001) 3.01

Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay. Breast Cancer Res (2006) 2.95

Transcriptional programs activated by exposure of human prostate cancer cells to androgen. Genome Biol (2002) 2.87

Systemic and cell type-specific gene expression patterns in scleroderma skin. Proc Natl Acad Sci U S A (2003) 2.87

Supervised clustering of genes. Genome Biol (2002) 2.86

Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms. BMC Genomics (2006) 2.86

Epithelial mesenchymal transition traits in human breast cancer cell lines. Clin Exp Metastasis (2008) 2.86

E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines. Br J Cancer (2006) 2.74

Prediction of clinical drug efficacy by classification of drug-induced genomic expression profiles in vitro. Proc Natl Acad Sci U S A (2003) 2.70

Molecular subsets in the gene expression signatures of scleroderma skin. PLoS One (2008) 2.66

Project normal: defining normal variance in mouse gene expression. Proc Natl Acad Sci U S A (2001) 2.66

Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray. Am J Pathol (2003) 2.59

Machine learning and its applications to biology. PLoS Comput Biol (2007) 2.57

MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18. J Exp Med (2010) 2.57

Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panel. Mol Cancer Ther (2006) 2.55

Gene expression patterns in ovarian carcinomas. Mol Biol Cell (2003) 2.55

Mei-P26 regulates microRNAs and cell growth in the Drosophila ovarian stem cell lineage. Nature (2008) 2.54

DNA fingerprinting of the NCI-60 cell line panel. Mol Cancer Ther (2009) 2.53

Comparing cDNA and oligonucleotide array data: concordance of gene expression across platforms for the NCI-60 cancer cells. Genome Biol (2003) 2.52

Enzyme activity profiles of the secreted and membrane proteome that depict cancer cell invasiveness. Proc Natl Acad Sci U S A (2002) 2.52

Discovery of novel splice forms and functional analysis of cancer-specific alternative splicing in human expressed sequences. Nucleic Acids Res (2003) 2.50

An alternative splicing network links cell-cycle control to apoptosis. Cell (2010) 2.43

Three microarray platforms: an analysis of their concordance in profiling gene expression. BMC Genomics (2005) 2.29

Sparse canonical methods for biological data integration: application to a cross-platform study. BMC Bioinformatics (2009) 2.26

Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA array. Genome Res (2001) 2.25

A genomic strategy to elucidate modules of oncogenic pathway signaling networks. Mol Cell (2009) 2.22

LSimpute: accurate estimation of missing values in microarray data with least squares methods. Nucleic Acids Res (2004) 2.22

Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness. Cancer Res (2002) 2.21

Identification of novel candidate target genes in amplicons of Glioblastoma multiforme tumors detected by expression and CGH microarray profiling. Mol Cancer (2006) 2.15

Bromodomain 4 activation predicts breast cancer survival. Proc Natl Acad Sci U S A (2008) 2.15

Current status of genome-wide association studies in cancer. Hum Genet (2011) 2.14

A decision support framework for genomically informed investigational cancer therapy. J Natl Cancer Inst (2015) 2.13

miR-1 induces growth arrest and apoptosis in malignant mesothelioma. Chest (2013) 2.11

A Landscape of Pharmacogenomic Interactions in Cancer. Cell (2016) 2.07

Hypoxia-induced gene expression profiling in the euryoxic fish Gillichthys mirabilis. Proc Natl Acad Sci U S A (2001) 2.07

Further evidence to support the melanocytic origin of MDA-MB-435. Mol Pathol (2002) 2.04

Feature selection and classification for microarray data analysis: evolutionary methods for identifying predictive genes. BMC Bioinformatics (2005) 2.03

Supervised harvesting of expression trees. Genome Biol (2001) 2.02

The rationale for targeting the LOX family in cancer. Nat Rev Cancer (2012) 2.02

Towards precise classification of cancers based on robust gene functional expression profiles. BMC Bioinformatics (2005) 2.01

Universal Reference RNA as a standard for microarray experiments. BMC Genomics (2004) 2.00

mRNA and microRNA expression profiles of the NCI-60 integrated with drug activities. Mol Cancer Ther (2010) 2.00

Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse. Breast Cancer Res Treat (2011) 1.96

Pharmacogenomic discovery using cell-based models. Pharmacol Rev (2009) 1.96

WholePathwayScope: a comprehensive pathway-based analysis tool for high-throughput data. BMC Bioinformatics (2006) 1.95

Cross-platform comparison and visualisation of gene expression data using co-inertia analysis. BMC Bioinformatics (2003) 1.93

Display technologies: application for the discovery of drug and gene delivery agents. Adv Drug Deliv Rev (2006) 1.92

Whole-genome DNA microarray analysis of a hyperthermophile and an archaeon: Pyrococcus furiosus grown on carbohydrates or peptides. J Bacteriol (2003) 1.92

Gene expression profiling of cutaneous wound healing. J Transl Med (2007) 1.91

3'-end sequencing for expression quantification (3SEQ) from archival tumor samples. PLoS One (2010) 1.91

Cytosine methylation profiling of cancer cell lines. Proc Natl Acad Sci U S A (2008) 1.91

Congruence of tissue expression profiles from Gene Expression Atlas, SAGEmap and TissueInfo databases. BMC Genomics (2003) 1.88

A compact VEGF signature associated with distant metastases and poor outcomes. BMC Med (2009) 1.84

CEBS--Chemical Effects in Biological Systems: a public data repository integrating study design and toxicity data with microarray and proteomics data. Nucleic Acids Res (2007) 1.80

Systematic discovery of structural elements governing stability of mammalian messenger RNAs. Nature (2012) 1.80

Gene expression in the normal adult human kidney assessed by complementary DNA microarray. Mol Biol Cell (2003) 1.79

Assessment of tumor characteristic gene expression in cell lines using a tissue similarity index (TSI). Proc Natl Acad Sci U S A (2005) 1.78

Gene-expression profiling of the response of peripheral blood mononuclear cells and melanoma metastases to systemic IL-2 administration. Genome Biol (2002) 1.74

Identification and validation of suitable endogenous reference genes for gene expression studies in human peripheral blood. BMC Med Genomics (2009) 1.73

PromoSer: A large-scale mammalian promoter and transcription start site identification service. Nucleic Acids Res (2003) 1.68

Core biopsies can be used to distinguish differences in expression profiling by cDNA microarrays. J Mol Diagn (2002) 1.67

Integrin alpha6beta4 controls the expression of genes associated with cell motility, invasion, and metastasis, including S100A4/metastasin. J Biol Chem (2008) 1.67

DNA methylation profiles of ovarian epithelial carcinoma tumors and cell lines. PLoS One (2010) 1.65

Triple negative breast cancer cell lines: one tool in the search for better treatment of triple negative breast cancer. Breast Dis (2010) 1.64

Integrative analysis of proteomic signatures, mutations, and drug responsiveness in the NCI 60 cancer cell line set. Mol Cancer Ther (2010) 1.62

A system for enhancing genome-wide coexpression dynamics study. Proc Natl Acad Sci U S A (2004) 1.61

Development of multifunctional nanoparticles for targeted drug delivery and noninvasive imaging of therapeutic effect. Curr Drug Discov Technol (2009) 1.60

DNA microarray analysis of the hyperthermophilic archaeon Pyrococcus furiosus: evidence for anNew type of sulfur-reducing enzyme complex. J Bacteriol (2001) 1.57

Multiclass classification of microarray data with repeated measurements: application to cancer. Genome Biol (2003) 1.55

Using DNA microarrays to study host-microbe interactions. Emerg Infect Dis (2000) 1.55

Rrp1b, a new candidate susceptibility gene for breast cancer progression and metastasis. PLoS Genet (2007) 1.55

Gene expression profiling reveals stromal genes expressed in common between Barrett's esophagus and adenocarcinoma. Gastroenterology (2006) 1.54

Component retention in principal component analysis with application to cDNA microarray data. Biol Direct (2007) 1.54

Hypoxia-inducible factor-1alpha and the glycolytic phenotype in tumors. Neoplasia (2005) 1.54

Phosphorylation and stabilization of HURP by Aurora-A: implication of HURP as a transforming target of Aurora-A. Mol Cell Biol (2005) 1.54

Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet (2000) 336.52

Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A (1998) 192.97

Molecular portraits of human breast tumours. Nature (2000) 94.14

Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science (1995) 88.48

Mapping mendelian factors underlying quantitative traits using RFLP linkage maps. Genetics (1989) 79.44

Construction of a genetic linkage map in man using restriction fragment length polymorphisms. Am J Hum Genet (1980) 75.25

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A (2001) 71.82

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature (2000) 64.32

Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet (2001) 63.36

Comprehensive identification of cell cycle-regulated genes of the yeast Saccharomyces cerevisiae by microarray hybridization. Mol Biol Cell (1998) 62.20

Exploring the metabolic and genetic control of gene expression on a genomic scale. Science (1997) 60.15

The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res (2004) 54.37

The transcriptional program of sporulation in budding yeast. Science (1998) 37.23

Genomic expression programs in the response of yeast cells to environmental changes. Mol Biol Cell (2000) 36.09

Two differentially regulated mRNAs with different 5' ends encode secreted with intracellular forms of yeast invertase. Cell (1982) 25.10

Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. Proc Natl Acad Sci U S A (1996) 24.18

A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization. Genome Res (1996) 23.16

Genomic binding sites of the yeast cell-cycle transcription factors SBF and MBF. Nature (2001) 21.55

Genetic and physical maps of Saccharomyces cerevisiae. Nature (1997) 21.48

Missing value estimation methods for DNA microarrays. Bioinformatics (2001) 20.84

Genetic engineering in vivo using translocatable drug-resistance elements. New methods in bacterial genetics. J Mol Biol (1977) 20.29

SGD: Saccharomyces Genome Database. Nucleic Acids Res (1998) 20.26

A Saccharomyces cerevisiae genomic plasmid bank based on a centromere-containing shuttle vector. Gene (1987) 19.68

Sterile host yeasts (SHY): a eukaryotic system of biological containment for recombinant DNA experiments. Gene (1979) 19.39

The transcriptional program in the response of human fibroblasts to serum. Science (1999) 19.19

Exploring the new world of the genome with DNA microarrays. Nat Genet (1999) 19.05

Integrating functional genomic information into the Saccharomyces genome database. Nucleic Acids Res (2000) 18.52

Singular value decomposition for genome-wide expression data processing and modeling. Proc Natl Acad Sci U S A (2000) 18.42

Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci U S A (2001) 17.36

A common language for physical mapping of the human genome. Science (1989) 17.36

Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet (1996) 15.73

Ensembl 2005. Nucleic Acids Res (2005) 15.13

Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat Genet (1999) 14.96

Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci U S A (1999) 14.16

Using the Saccharomyces Genome Database (SGD) for analysis of protein similarities and structure. Nucleic Acids Res (1999) 13.65

A gene expression database for the molecular pharmacology of cancer. Nat Genet (2000) 13.31

Promoter-specific binding of Rap1 revealed by genome-wide maps of protein-DNA association. Nat Genet (2001) 13.05

DNA arrays for analysis of gene expression. Methods Enzymol (1999) 12.50

Gene expression informatics--it's all in your mine. Nat Genet (1999) 12.35

Ensembl 2002: accommodating comparative genomics. Nucleic Acids Res (2003) 12.26

Homozygosity mapping: a way to map human recessive traits with the DNA of inbred children. Science (1987) 12.20

Ensembl 2004. Nucleic Acids Res (2004) 11.88

Ensembl 2006. Nucleic Acids Res (2006) 11.66

An information-intensive approach to the molecular pharmacology of cancer. Science (1997) 11.43

Mutagenesis by insertion of a drug-resistance element carrying an inverted repetition. J Mol Biol (1975) 11.14

Correct integration of retroviral DNA in vitro. Cell (1987) 10.73

Structure and function of the yeast URA3 gene: expression in Escherichia coli. Gene (1984) 10.07

Drug target validation and identification of secondary drug target effects using DNA microarrays. Nat Med (1998) 9.72

Low back pain. N Engl J Med (2001) 9.70

SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett (1995) 9.62

Strategies for studying heterogeneous genetic traits in humans by using a linkage map of restriction fragment length polymorphisms. Proc Natl Acad Sci U S A (1986) 9.51

A nucleoprotein complex mediates the integration of retroviral DNA. Genes Dev (1989) 8.80

Phenotypic analysis of temperature-sensitive yeast actin mutants. Cell (1985) 8.53

Mapping complex genetic traits in humans: new methods using a complete RFLP linkage map. Cold Spring Harb Symp Quant Biol (1986) 8.22

Gaussian models for genetic linkage analysis using complete high-resolution maps of identity by descent. Am J Hum Genet (1993) 8.05